Epithelial cell adhesion molecule (redirect from EpCAM)
Epithelial cell adhesion molecule (EpCAM), also known as CD326 among other names, is a transmembrane glycoprotein mediating Ca2+-independent homotypic...
20 KB (2,451 words) - 12:05, 4 April 2024
EpCAM. It was developed by Fresenius Biotech and Trion Pharma (Germany). The drug is used for the treatment of malignant ascites in people with EpCAM-positive...
8 KB (709 words) - 20:33, 1 December 2023
DNA mutation in one of the MMR genes (MLH1, MSH2, MSH6, and PMS2) or the EPCAM gene, identified by genetic testing. Candidates for germline genetic testing...
47 KB (4,902 words) - 21:19, 19 February 2024
use in the European Union in June 2022. Solitomab links T cells with the EpCAM antigen which is expressed by colon, gastric, prostate, ovarian, lung, and...
9 KB (1,471 words) - 05:15, 1 July 2024
aid in the diagnosis of basal cell carcinoma (BCC). It is an antibody to EpCAM (epithelial cell adhesion molecule). BerEp4 has a high sensitivity and specificity...
3 KB (210 words) - 23:22, 15 December 2021
One of the scFvs binds to T cells via the CD3 receptor, and the other to EpCAM as a tumor antigen against gastrointestinal, lung, and other cancers. Like...
3 KB (256 words) - 16:20, 9 February 2023
levels of EpCAM-positive cells. Patients with severe skin burns can also carry EpCAM positive cells in the blood. Therefore, the use of EpCAM-positive...
67 KB (8,163 words) - 17:26, 27 April 2024
a monoclonal antibody which binds to epithelial cell adhesion molecule (EpCAM, the tumor-associated calcium signal transducer 1). Oportuzumab is fused...
3 KB (225 words) - 23:43, 17 July 2024
(thyroid transcription factor-1) Podoplanin (PDPN) Claudin-4 Osteopontin Epithelial cell adhesion molecule (EpCAM) Estrogen receptor alpha Mammaglobin...
96 KB (10,697 words) - 06:49, 13 May 2024
idiopathic arthritis, hemolytic disease of the newborn Adecatumumab mab human EpCAM prostate and breast cancer Aducanumab Aduhelm mab human Amyloid beta Y Alzheimer's...
135 KB (4,054 words) - 22:35, 2 July 2024